Determination in Biological Technology

Anesiva Receives NASDAQ Delisting Staff Determination Letter

SOUTH SAN FRANCISCO, Calif., July 23 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) received, as previously disclosed on its Current Report on Form 8-K filed with the Securities and Exchange Commission on April 2, 2009 and in its press release on April 1, 2009, a letter from t...

EPA Refuge Determination Positive for the Environment

The National Corn Growers Association is pleased the U.S. Environmental Protection Agency will allow farmers the ability to improve upon the environmental benefits from biotechnology corn. The EPA has announced a reduced refuge requirement for SmartStax, an insect-protection and weed control pla...

XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel

REHOVOT, Israel, April 16 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XTL) today announced that on April 15, 2009, it received notification from The Nasdaq Stock Market ("Nasdaq") that the Nasdaq Listing Qualifications Panel (the "Panel") has determined that t...

deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter

REYKJAVIK, Iceland, November 4 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN ) today announced today that it has requested a hearing before a Nasdaq Listing Qualifications Panel to present a plan for regaining compliance with Nasdaq Marketplace Rule 4450(b)(1)(A), which requires a mi...

Cell Therapeutics to Request a Hearing With NASDAQ Following Receipt of Staff Determination Letter

SEATTLE, Oct. 10 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Company intends to request a hearing with the NASDAQ Listing Qualifications Panel to present a plan for regaining compliance with NASDAQ Marketplace Rule 4450(b)(1)(A), whic...

Memory Pharmaceuticals Receives Anticipated NASDAQ Staff Determination Letter

- Company to Request a Hearing - MONTVALE, N.J., June 9 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) today announced that on June 6, 2008 it received a letter from the NASDAQ Listing Qualifications Department notifying the Company that, because it...

Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization

- Company Plans to Request Timely Hearing before a NASDAQ Listing Qualifications Panel - FREMONT, Calif., March 28 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML , VRMLD) (the "Company"), a molecular diagnostics company, announced today that on March 18, 2...

Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin

SUNNYVALE, Calif., Nov. 6 /PRNewswire/ -- Pathwork Diagnostics, a genomics-based diagnostics company focused on oncology, announced today that Virginia Commonwealth University School of Medicine has initiated an investigational study of the Pathwork(TM) Tissue of Origin Test. The new genomics-...

Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination

RICHMOND, Va., June 20 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today announced that it intends to request a hearing before The NASDAQ Listing Qualifications Panel ('the Panel") to appeal an earlier Staff Determination to ...

Enhanced Protein Tomography(TM) Method for Rapid Epitope Determination

STOCKHOLM, Sweden, June 5 /PRNewswire/ -- Sidec has of today introduced a new version of its Protein Tomography(TM) technology. The new developments drastically improve the analysis of therapeutic antibodies and drug targets in biological systems. (Logo: http://www.newscom.com/cgi-bin/prnh/...

NexGen Biofuels Ltd. (Nasdaq: NXGN) Announces Receipt of Nasdaq Delisting Determination

NEW YORK, February 27 /PRNewswire-FirstCall/ -- NexGen Biofuels Ltd. (f/k/a Healthcare Technologies Ltd.) (the "Company") announced today that on February 26, 2008, the Company received a letter from the Nasdaq Listing Qualification Panel, informing the Company that the Panel had determined to...

Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination

SEATTLE, Aug. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) today announced that it had received a Deficiency Letter (the "Letter") from Nasdaq indicating that the Company's recently completed registered offering of Series C 3% Convertible Preferred Stock (...

A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20)

INTRODUCTION β -lactamases are either plasmid or chromosomally encoded bacterial enzymes which hydrolyze β -lactam antibiotics. The majority of β -lactamases produced by clinical isolates are serine active site enzymes. One successful approach to combat...

Fluorescence assay for determination of protease activity

In research and industrial work it is quite often necessary to test whether samples or solutions are free of protease activity. Using commercially available kits e.g. from Molecular Probes Inc., protease activity can be measured with the new fluorometer from PerkinElmer Life Sciences, VIC...

Kinetic determination of vitamin B1

Abstract Kinetic fluorescence as an analytical technique to quantify non-fluorescent species is described, and the technique is applied to the determination of thiamine (vitamin B 1 ) in solution. Fluorescence intensity is monitored as thiamine converts to fluorescent...

A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors)

Purpose In clinical research, the monitoring of protease inhibitor (PI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) antiretroviral drugs is of significant interest due to the importance of assessing inter-individual and intra-individual metabolism variability. ...

Simultaneous Determination of Residues of Approximately 100 Pesticides and Metabolites in Fruit and Vegetables by LC/MS/MS

Many pesticides, which are difficult or generally not to analyse by GC/MS, can be identified and quantified by LC/MS/MS. After simple solvent extraction and fast cleanup the extracts are analysed using matrix-matched standards. The drawback of MS/MS meth...

Total Cellular Protein Determination Using the DC Protein Assay

Introduction The DC Protein Assay reagents contain both detergent and base which are required for cell lysis of many cell samples prior to determination of total cellular protein. The following protocol can be used for tissue cells; dry cells; protein ...

Structural Determination of Flavonoids Using MSn

Jack Cunniff, Philip Tiller, Michael Harvey, and Adrian Land, Thermo Finnigan Natural Product Analysis The data presented here can be acquired using the Thermo Finnigan LCQ Se...

ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA

...ethod for assessing total adiponectin available from the same manufacturer. Given the lack of an international reference standard for adiponectin, the determination of both HMW and total adiponectin using the same ELISA is preferable to eliminate this source of bias in the ratio. The interest in animal mode...

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

...R), RHD and fetal sex determination. The first of these tests - CFTR - is expected to launch this quarter or early next quarter. The RHD and fetal sex determination tests are on target for launches thereafter. Down Syndrome Test - The company is evaluating both RNA and DNA approaches for a Down syndrome t...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

...nt; our dependence on sales to a limited number of large pharmacy chains and wholesale drug distributors for a large portion of our total net sales; a determination by a regulatory agency that we are engaging in inappropriate sales or marketing activities, including promoting the "off-label" use of our products; t...

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

..., to authorize the use of unapproved or uncleared medical products or unapproved or uncleared uses of approved or cleared medical products following a determination and declaration of emergency, provided certain criteria are met. In the case of the Influenza A H1N1 (2009) Real Time RT-PCR, the FDA has only authori...

TorreyPines Receives Notice of Delisting from Nasdaq Global Market

...q Listing Qualifications Panel to review the Staff determination to delist the Company's common stock. The request for a hearing will stay the Staff determination to delist the Company's common stock until the Panel renders a determination following the hearing. The hearing is expected to ...

VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ

...diovascular and metabolic disease, today announced that it received a Staff determination letter, dated July 15, 2009, from the NASDAQ Stock Market stating that the ... Market. The Company intends to file an appeal of the NASDAQ Staff determination by July 22, 2009 and to request a hearing before a NASDAQ Listing Qualifica...

Monitoring water through a snake's eyes

.... Katzir are made of insoluble, non-toxic, and biocompatible materials. "You can eat them and nothing will happen to you," he notes. Prof. Katzir's determination to fight terrorism through science has a personal side as well. His father, world-renowned scientist Prof. Aharon Katzir, was assassinated by the Japa...

ForteBio Launches Two Revolutionary High-Throughput, Label-Free Instruments: The Octet(R) RED384 and the Octet QK384

...ng ELISA or SPR-based methods," said Christopher Silva, ForteBio's vice president of marketing. "For example, using our new instrumentation, IgG titer determination can be completed in less than 20 minutes, as opposed to four to five hours using traditional ELISA methods. This fast time-to-result is important for ...

CEM Wins Presidential Green Chemistry Challenge Award for the Sprint Rapid Protein Analyzer

...ectly "tag" the protein with an environmentally-benign solution, yielding accurate results in minutes. The adaptation of the Sprint System for protein determination in foods will eliminate the estimated 2.5 million kilograms of hazardous waste used in Kjeldahl tests every year in the US. Sprint's method is approve...

Victhom announces completion of joint venture agreement with Otto Bock for Neurobionix activities

..."On behalf of Victhom, I want to acknowledge Stephane's remarkable work during all those years. Victhom came to life thanks to his insight, talent and determination and the Corporation could never have achieved this level of development without his valuable contribution. We would like to wish the best success to S...

FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout

...omic, political and other risks associated with foreign operations; risks of maintaining protection for our intellectual property; risks of an adverse determination in intellectual property litigation; and risks associated with stringent government regulation of the biopharmaceutical industry and other important f...

Cell Therapeutics on Preliminary List of Additions to Russell 3000(R) Index and Russell Global(R) Index

... Final determination to be made on June 26, 2009 SEATTLE, June 15 /PRNewswire-FirstCall/ --...I's inclusion in the Russell 3000 Index and the Russell Global Index or a determination by Russell Investments not to include CTI in the Russell 3000 Index and the...

Frost & Sullivan Recognizes Cisbio Bioassays for Technology Innovation

...rization of 7TM receptors by employing fluorescence technologies. "The determination of ligand binding affinity has been used to delineate the ligand binding si...oassays' Tag-lite(TM) technology is innovative and unique. It has aided the determination of ligand binding affinities without the use of radioactivity and with comp...

Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting

...representing half of the patients still alive at the time of analysis. Progression-free survival (PFS) in these patients ranged from 8 to 13 months. determination of the impact of AT-101 on overall survival (OS), the primary endpoint, is ongoing. AT-101 in Lung Cancer Reports from two studies in lung ...

Structure of enzyme against chemical warfare agents determined

...neutron source at Los Alamos National Laboratory, one of only three sources worldwide equipped for protein crystallography. In contrast to structure determination using X-rays, neutrons are able to locate the positions of hydrogen atoms, which make up half of all atoms in proteins, and are crucial for chemical...

Monitoring water through a snake's eyes

.... Katzir are made of insoluble, non-toxic, and biocompatible materials. "You can eat them and nothing will happen to you," he notes. Prof. Katzir's determination to fight terrorism through science has a personal side as well. His father, world-renowned scientist Prof. Aharon Katzir, was assassinated by the Japa...

Spherix Regains Full NASDAQ Compliance

...8, 2009, the Company received notification from NASDAQ confirming that it has regained compliance with the independent director requirement. NASDAQ's determination was based on the Company's appointment of Thomas B. Peter to the Company's Board of Directors. Mr. Peter has spent more than 33 years working at Glax...

Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice

...written notice that the Company's common stock will be delisted from the NASDAQ Global Market. At such time, the Company may appeal NASDAQ's delisting determination to a NASDAQ Listing Qualifications Panel or may apply to list its common stock on the NASDAQ Capital Market. The NASDAQ Capital Market is a continuou...

Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting

... Date: Sunday, May 31, 2009 POSTER DISCUSSION Abstract #518 Time: 8:00AM - 12:00PM Location: Level 2, West Hall D1, W240A Early determination of metastatic potential in breast cancer: the 70-gene signature in small tumors M. Knauer, S. Mook, V. Retel, M. Kok, J. Wesseling, A. M. Glas...

VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R)

...The test, which doesn't require fasting, provides direct measurements of LDL, HDL and all relevant subclasses, and includes non-HDL, a highly accurate determination of apoB, and emerging risk factors such as Lp(a), remnants and small dense LDL. "We are excited to bring the VAP Test directly to consumers at su...

deCODE genetics Announces First Quarter 2009 Financial Results

...n April 28, deCODE received a letter from the Nasdaq Listing and Hearing Review Council stating that the Council has called for review the determination of the Nasdaq Listing Qualifications Panel regarding the delisting of the company's common stock from the Nasdaq Stock Market. Pending the...